Author:
Sun Yeting,Huang Sicheng,Zhang Bo,Peng Yu,Lu Hui,Jia Yimeng,Sun Rui-jie,Zhang Fenghua,Zhou Jiaxin,Peng Linyi,Li Mengtao,Zhang Wen,Fei Yunyun
Reference53 articles.
1. IgG4-related disease: an update on pathophysiology and implications for clinical care;C A Perugino;Nat Rev Rheumatol,2020
2. IgG4-related disease;J H Stone;The New England journal of medicine,2012
3. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes;M Lanzillotta;Rheumatology,2020
4. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial;Y Wang;Seminars in arthritis and rheumatism,2020
5. Comparison of the Effects of Cyclophosphamide and Mycophenolate Mofetil Treatment Against Immunoglobulin G4-Related Disease: A Retrospective Cohort Study;X Luo;Frontiers in medicine,2020